Cresset BioMolecular Discovery Limited
Cresset BioMolecular Discovery Limited, a leading name in the field of computational chemistry and molecular modelling, is headquartered in Great Britain. Founded in 2003, the company has established itself as a key player in the pharmaceutical and biotechnology industries, providing innovative solutions for drug discovery and development. Cresset's core offerings include advanced software tools for molecular design, virtual screening, and predictive modelling, which are distinguished by their unique ability to enhance the efficiency of the drug discovery process. With a strong focus on user-friendly interfaces and robust algorithms, Cresset's products empower researchers to make informed decisions quickly. Recognised for its contributions to the field, Cresset has achieved significant milestones, including collaborations with major pharmaceutical companies and a growing presence in global markets. The company continues to drive innovation, solidifying its position as a trusted partner in the quest for new therapeutics.
DitchCarbon Score
How does Cresset BioMolecular Discovery Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cresset BioMolecular Discovery Limited's score of 23 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Cresset BioMolecular Discovery Limited's reported carbon emissions
Cresset BioMolecular Discovery Limited, headquartered in Great Britain, currently does not have any publicly available carbon emissions data or specific reduction targets. Without reported emissions figures, it is unclear how the company is addressing its carbon footprint or what commitments it has made towards climate action. In the absence of concrete data, it is essential to monitor industry trends and best practices in sustainability to understand how Cresset may align with broader climate initiatives in the biotechnology sector.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cresset BioMolecular Discovery Limited is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
